Whitehawk Therapeutics (WHWK) Net Margin (2018 - 2025)
Whitehawk Therapeutics (WHWK) posted quarterly Net Margin of 1021.92% for Q1 2025, up 138943.0% year-over-year from N/an in Q1 2024, and up 577.82% quarter-over-quarter from 213.87% in Q4 2024.
Whitehawk Therapeutics (WHWK) Net Margin (2018 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Net Margin for 7 consecutive years, with 1021.92% the latest figure, recorded in Q1 2025.
- In Q1 2025, Net Margin rose 138943.0% year-over-year to 1021.92%; the TTM figure through Dec 2025 stood at 416.0% (down 17032.0% YoY), while the FY2025 annual figure was 227.73%, up 1740.0% from the prior year.
- Net Margin rose to 1021.92% in Q1 2025 per WHWK's latest filing, from 213.87% in the prior quarter.
- Across five years, Net Margin topped out at 1021.92% in Q1 2025 and bottomed at 3701.45% in Q1 2021.
- Historically, Net Margin has averaged 442.0% across 5 years, with a median of 266.18% in 2022.
- Annual changes were most pronounced in 2021 — Net Margin slumped 17149 bps — and 2022, when it soared 310080 bps.
- Whitehawk Therapeutics' Net Margin stood at 114.21% in 2021, then tumbled by 133 bps to 266.18% in 2022, then rose by 3 bps to 257.18% in 2023, then advanced by 17 bps to 213.87% in 2024, then soared by 578 bps to 1021.92% in 2025.
- Business Quant data shows WHWK's Net Margin at 1021.92% in Q1 2025, 213.87% in Q4 2024, and 177.44% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1,021.92% |
| Dec 31, 2024 | -213.87% |
| Sep 30, 2024 | -177.44% |
| Jun 30, 2024 | -257.05% |
| Mar 31, 2024 | -367.51% |
| Dec 31, 2023 | -257.18% |
| Sep 30, 2023 | -273.57% |
| Jun 30, 2023 | -289.76% |
| Mar 31, 2023 | -260.59% |
| Dec 31, 2022 | -266.18% |
| Sep 30, 2022 | -340.97% |
| Jun 30, 2022 | -531.54% |
| Mar 31, 2022 | -600.65% |
| Dec 31, 2021 | -114.21% |
| Mar 31, 2021 | -3,701.45% |
| Dec 31, 2020 | 57.28% |
| Sep 30, 2020 | -1,251.52% |
| Jun 30, 2020 | 61.84% |
| Dec 31, 2018 | -397,322.29% |
| Sep 30, 2018 | 61.30% |